Skip to main content

Palo Alto Investors LP

Position in NVCR — NovoCure Ltd

CIK 1306923 PALO ALTO, CA

Position in NVCR

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$19,398,650
+$5,441,865 QoQ
Shares Held
1,280,439
0.0% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
2.68%
of 13F equity value
Holder Rank
#14
of 217 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Palo Alto Investors LP holds $22,833,042 across 3 Medical Devices names. NVCR ranks #1 (85.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVCR
NovoCure Ltd
This page
1,280,439 $19,398,650

All Filings in NVCR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,398,650 1,280,439
2026-03-31 $13,956,785 1,280,439
2025-12-31 $16,795,604 1,298,964
2025-09-30 $16,229,574 1,256,159
2025-06-30 $17,130,648 962,396
2025-03-31 $17,856,727 1,002,061
2024-12-31 $24,262,891 814,191
2024-09-30 $9,277,030 593,540
2024-06-30 $9,625,484 561,908
2024-03-31 $8,782,622 561,908
2023-12-31 $8,389,286 561,908
2023-09-30 $10,663,441 660,275
2023-06-30 $23,991,897 578,118
2023-03-31 $1,971,990 32,790